Isolation and growth of smooth muscle-like cells derived from tuberous sclerosis complex-2 human renal angiomyolipoma: epidermal growth factor is the required growth factor.
about
Real-time monitoring of tumorigenesis, dissemination, & drug response in a preclinical model of lymphangioleiomyomatosis/tuberous sclerosis complexAnti-EGFR antibody efficiently and specifically inhibits human TSC2-/- smooth muscle cell proliferation. Possible treatment options for TSC and LAM.Lymphangioleiomyomatosis and TSC2-/- cellsTSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival.Anti-EGFR antibody reduces lung nodules by inhibition of EGFR-pathway in a model of lymphangioleiomyomatosis.Survivin expression in tuberous sclerosis complex cells.Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor geneThe methylation of the TSC2 promoter underlies the abnormal growth of TSC2 angiomyolipoma-derived smooth muscle cellsOncogenic effects of urotensin-II in cells lacking tuberous sclerosis complex-2Endothelial and smooth muscle cells derived from human cardiac explants demonstrate angiogenic potential and suitable for design of cell-containing vascular grafts.Injury-induced expression of cytokeratins 8 and 18 by vascular smooth muscle cells requires concurrent activation of cytoskeletal and growth factor receptors.Detection of low-prevalence somatic TSC2 mutations in sporadic pulmonary lymphangioleiomyomatosis tissues by deep sequencing.Mesenchymal Tumorigenesis Driven by TSC2 Haploinsufficiency Requires HMGA2 and Is Independent of mTOR Pathway Activation.Lymphangioleiomyomatosis--presence of receptor tyrosine kinases and the angiogenesis factor VEGF-A as potential therapeutic targetsThe LAM Lung Cell and Its Human Cell Models.Glioblastoma multiforme in a child with tuberous sclerosis complex.Human renal angiomyolipoma cells of male and female origin can migrate and are influenced by microenvironmental factors.
P2860
Q27301399-4DFC4A2F-C8A3-41A4-85AD-1E9577BDA1F4Q33380187-65D9EEA5-CB1B-4295-9B53-EE9081E930FFQ33904951-5D78261E-38C3-4081-A799-7E6CCF9D89BBQ33991599-F8D12FA5-2848-4E77-A99E-050E96492AAEQ35074335-07183241-832E-4FCA-83C8-F180248489B0Q35844066-247C5E5A-669D-4B69-88C5-DC28869BCBEBQ37149062-47AEC74E-60A5-48DF-9CB1-28151E4BBEA9Q37197352-7B130B4C-A6CB-4700-BC77-BEC1DC30C861Q37641575-DB3DF2E5-F135-495D-A71E-3FFAF4AABF4BQ37680222-A8946AA5-7835-45E6-9123-FF39800DDCDFQ38501337-909BFDD9-5785-4EB7-B0BA-E88FC4C21396Q40330232-CACB7291-1708-41AD-A670-A1B620B00E78Q41365464-7DE04915-6E05-4AD7-AFBE-572BD0D41DBCQ42764754-5B7C3924-218C-406E-B69B-FD69B0418544Q50181460-2A4385EA-50AA-4F70-ADEB-60326F07D660Q53517722-0C4A388E-94C5-4491-A95F-2BB513F4AB64Q55260504-D6463E7B-C06D-42D7-A455-CCF0FE99939F
P2860
Isolation and growth of smooth muscle-like cells derived from tuberous sclerosis complex-2 human renal angiomyolipoma: epidermal growth factor is the required growth factor.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Isolation and growth of smooth ...... is the required growth factor.
@ast
Isolation and growth of smooth ...... is the required growth factor.
@en
type
label
Isolation and growth of smooth ...... is the required growth factor.
@ast
Isolation and growth of smooth ...... is the required growth factor.
@en
prefLabel
Isolation and growth of smooth ...... is the required growth factor.
@ast
Isolation and growth of smooth ...... is the required growth factor.
@en
P2093
P2860
P1476
Isolation and growth of smooth ...... is the required growth factor.
@en
P2093
Alfredo Gorio
Anna Maria Di Giulio
Diego Brancaccio
Elena Lesma
Guido Coggi
Maria Paola Canevini
Rosa Maria Alfano
Stephana Carelli
Vera Grande
P2860
P304
P356
10.1016/S0002-9440(10)61198-4
P407
P577
2005-10-01T00:00:00Z